Invention Grant
- Patent Title: PCV2 ORF2 carrier platform
-
Application No.: US15562167Application Date: 2016-03-29
-
Publication No.: US10555994B2Publication Date: 2020-02-11
- Inventor: Luis Alejandro Hernandez , Eric Martin Vaughn
- Applicant: Boehringer Ingelheim Animal Health USA Inc.
- Agent Judy Jaracki-Black
- International Application: PCT/US2016/024631 WO 20160329
- International Announcement: WO2016/160761 WO 20161006
- Main IPC: A61K39/12
- IPC: A61K39/12 ; C07K14/005 ; C12N15/62 ; C07K1/14 ; G01N33/53 ; G01N33/566 ; A61P31/20 ; A61K39/00

Abstract:
The present invention relates to an immunogen-carrier, wherein the immunogen-carrier is preferably a virus-like particle (VLP) composed of a plurality of a modified PCV2 ORF2 protein. In particular, the present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a compliance marker for vaccines including a subunit antigen, and a DIVA (Differentiating Infected from Vaccinated Animals) system which makes it possible to differentiate between animals infected with a pathogen and animals treated with a subunit antigen derived from said pathogen.
Public/Granted literature
- US20180344835A1 PCV2 ORF2 CARRIER PLATFORM Public/Granted day:2018-12-06
Information query